Search results for " vino"

La cooperazione vitivinicola in Sicilia: aspetti economico aziendali (2. ed.)

2012

Studio di alcuni aspetti dell’Enoturismo in Sicilia.

2008

L’etichettatura di sostenibilità nel settore vitivinicolo

2022

Nel settore vitivinicolo la sostenibilità e la sua comunicazione al consumatore per mezzo dell’etichettatura, nel rispetto della normativa in materia, ha assunto una crescente rilevanza, anche in ragione delle pressanti esigenze ambientali e climatiche che costringono ad un ripensamento in chiave digitale di sistemi e tecniche di produzione, in un’ottica di ottimizzazione e preservazione delle risorse naturali. Partendo da una preliminare riflessione circa il significato giuridico del termine “sostenibile”, il contributo si sofferma su come il legame tra iniziativa imprenditoriale, sviluppo di innovative tecnologie digitali, ricerca di nuovi spazi di mercato e sicurezza giuridica abbia anc…

Impiego enologico di un ceppo di Kluyveromyces marxianus isolato a Linosa

2014

C'è dell'ananas nel vino? Descrizioni enologiche tra parassitaggio e modulazione pragmatica

2019

In questo articolo analizzeremo lo statuto semiotico-cognitivo dei descrittori dei vini comunemente utilizzati per asserire che un determinato vino ha sentore di frutta. Infatti, una delle caratteristiche più evidenti del lessico usato oggi per parlare del vino è la sua parentela con il lessico della frutta. Mostreremo come questa parentela tra lessico enologico e lessico della frutta si basi su un processo di dipendenza e non sia un generico fenomeno di prestito linguistico. Si tratta, infatti di un processo parassitario che trasforma il lessico della frutta da lessico asistematico con funzione denotativa – per cui con il termine “ananas” intendiamo riferirci agli ananas nel mondo – in un …

Médoc:itinerario enologico turistico

2009

Treatment of metastatic breast cancer with vinorelbine and docetaxel.

2006

Objective: A phase II study was performed to evaluate efficacy and safety of the combination vinorelbine and docetaxel in patients with metastatic breast cancer previously treated with anthracycline-based regimens. Overall 41 patients were included in the study. Methods: Treatment consisted of vinorelbine 25 mg/m 2 and docetaxel 75 mg/m 2 , both administered on day 1 every 3 weeks for a maximum of 9 cycles. Most patients (92%) were postmenopausal with a median age of 57 years, and median ECOG performance of 1. Sites of disease were viscera in 42% of patients, bones in 30%, soft-tissues in 32%. Sixty-five percent of patients had >2 metastatic sites. Previous treatments included neo-adjuvant …

Italian Survey on adjuvant treatment of non-small cell lung cancer (ISA)

2011

Background: A recent pooled analysis of randomized trials indicated significant improvement in overall survival from cisplatin-based adjuvant chemotherapy for non-small cell lung cancer (NSCLC), depending on disease stage (only in stages II and III) and PS (≤1). Post-operative radiotherapy (RT) is optional for pN2 tumours. Patients and methods: To evaluate opinions and daily clinical practice of Italian Oncologists about adjuvant treatment of NSCLC, a 46-item questionnaire was delivered via e-mail. Results: Seventy-eight physicians from 68 Centers (out of 98 contacted) returned their questionnaire. Seventy-four, 86, 94, and 78% of them give the indication for adjuvant chemotherapy for stage…

Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study

2021

Abstract Purpose Triple-negative breast cancer (TNBC) represents a subtype of breast cancer which lacks the expression of oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor-2 (HER2): TNBC accounts for approximately 20% of newly diagnosed breast cancers and is associated with younger age at diagnosis, greater recurrence risk and shorter survival time. Therapeutic options are very scarce. Aim of the present analysis is to provide further insights into the clinical activity of metronomic chemotherapy (mCHT), in a real-life setting. Methods We used data included in the VICTOR-6 study for the present analysis. VICTOR-6 is an Italian multicentre retrosp…

Phase I-II trial of gemcitabine-based first-line chemotherapies for small cell lung cancer in elderly patients with performance status 0-2: the G-STE…

2011

Introduction: Treatment of elderly patients with small cell lung cancer (SCLC) is based on scanty evidence. Methods: Patients with extensive SCLC, age >70 years, and performance status 0-2 were eligible for a study looking for optimal two-drug combination of gemcitabine (Gem) with vinorelbine (Vin), etoposide (Eto), cisplatin (Cis), or carboplatin (Car). Gemcitabine dose was the same (1000 mg/m2, days 1-8) in all combinations. A two-stage minimax flexible design for response was applied to GemVin combination (Vin 25 mg/m2, days 1-8). For GemCar, GemCis, GemEto, a phase I-II Bayesian design was applied, looking for the optimal dose of the partner drugs. Objective response rate ≥60% and un…